drugset / Trial / NCT02116309

Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis

NCT02116309

RandomizedParallel-groupQuadruple-blindPrevention

Summary

This research is being done to see if using a combination of rectal indomethacin and epinephrine spray during endoscopy, can prevent pancreatitis that may occur after ERCP (a type of gastrointestinal endoscopy).

Timeline

Start
2014-08
Primary completion
2016-12-02
Completion
2016-12-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Epinephrine Other / unclassified 0.02 % Topical
Comparator Epinephrine Other / unclassified 20 ml Topical
Comparator Indomethacin Small molecule 100 mg Rectal

Indications